NUVB
NYSE · Pharmaceuticals
Nuvation Bio Inc
$4.22
-0.04 (-0.94%)
Open$4.26
Previous Close$4.26
Day High$4.38
Day Low$4.15
52W High$9.75
52W Low$1.54
Volume—
Avg Volume4.14M
Market Cap1.48B
P/E Ratio—
EPS$-0.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+924.2% upside
Current
$4.22
$4.22
Target
$43.22
$43.22
$30.63
$43.22 avg
$69.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 61.43M | 781.90M | 798.00M |
| Net Income | -199,803,155 | 141.36M | 136.11M |
| Profit Margin | -325.3% | 18.1% | 17.1% |
| EBITDA | -205,672,852 | 195.91M | 227.47M |
| Free Cash Flow | — | 85.45M | 83.04M |
| Rev Growth | — | +23.6% | -6.7% |
| Debt/Equity | 0.68 | 0.84 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |